» Articles » PMID: 35633391

Semi-Implantable Bioelectronics

Overview
Journal Nanomicro Lett
Publisher Springer
Date 2022 May 28
PMID 35633391
Authors
Affiliations
Soon will be listed here.
Abstract

Developing techniques to effectively and real-time monitor and regulate the interior environment of biological objects is significantly important for many biomedical engineering and scientific applications, including drug delivery, electrophysiological recording and regulation of intracellular activities. Semi-implantable bioelectronics is currently a hot spot in biomedical engineering research area, because it not only meets the increasing technical demands for precise detection or regulation of biological activities, but also provides a desirable platform for externally incorporating complex functionalities and electronic integration. Although there is less definition and summary to distinguish it from the well-reviewed non-invasive bioelectronics and fully implantable bioelectronics, semi-implantable bioelectronics have emerged as highly unique technology to boost the development of biochips and smart wearable device. Here, we reviewed the recent progress in this field and raised the concept of "Semi-implantable bioelectronics", summarizing the principle and strategies of semi-implantable device for cell applications and in vivo applications, discussing the typical methodologies to access to intracellular environment or in vivo environment, biosafety aspects and typical applications. This review is meaningful for understanding in-depth the design principles, materials fabrication techniques, device integration processes, cell/tissue penetration methodologies, biosafety aspects, and applications strategies that are essential to the development of future minimally invasive bioelectronics.

Citing Articles

Asthma management in the digital age.

Bocian I, Chin A, Rodriguez A, Collins W, Sindher S, Chinthrajah R Front Allergy. 2024; 5:1451768.

PMID: 39291253 PMC: 11405314. DOI: 10.3389/falgy.2024.1451768.


Fabrication of Multiple-Channel Electrochemical Microneedle Electrode Array via Separated Functionalization and Assembly Method.

Huang X, Huang S, Zheng S, Liang B, Zhang T, Yue W Biosensors (Basel). 2024; 14(5).

PMID: 38785717 PMC: 11118220. DOI: 10.3390/bios14050243.


Active Micro-Nano-Collaborative Bioelectronic Device for Advanced Electrophysiological Recording.

Xiang Y, Shi K, Li Y, Xue J, Tong Z, Li H Nanomicro Lett. 2024; 16(1):132.

PMID: 38411852 PMC: 10899154. DOI: 10.1007/s40820-024-01336-1.


Hydrogel-Based Bioelectronics and Their Applications in Health Monitoring.

Hua J, Su M, Sun X, Li J, Sun Y, Qiu H Biosensors (Basel). 2023; 13(7).

PMID: 37504095 PMC: 10377104. DOI: 10.3390/bios13070696.


Flexible Monitoring, Diagnosis, and Therapy by Microneedles with Versatile Materials and Devices toward Multifunction Scope.

Wang S, Zhao M, Yan Y, Li P, Huang W Research (Wash D C). 2023; 6:0128.

PMID: 37223469 PMC: 10202386. DOI: 10.34133/research.0128.


References
1.
Hu M, Li L, Wu H, Su Y, Yang P, Uttamchandani M . Multicolor, one- and two-photon imaging of enzymatic activities in live cells with fluorescently Quenched Activity-Based Probes (qABPs). J Am Chem Soc. 2011; 133(31):12009-20. DOI: 10.1021/ja200808y. View

2.
Oliver N, Toumazou C, Cass A, Johnston D . Glucose sensors: a review of current and emerging technology. Diabet Med. 2009; 26(3):197-210. DOI: 10.1111/j.1464-5491.2008.02642.x. View

3.
Yu J, Wang J, Zhang Y, Chen G, Mao W, Ye Y . Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs. Nat Biomed Eng. 2020; 4(5):499-506. PMC: 7231631. DOI: 10.1038/s41551-019-0508-y. View

4.
Liu R, Chen R, Elthakeb A, Lee S, Hinckley S, Khraiche M . High Density Individually Addressable Nanowire Arrays Record Intracellular Activity from Primary Rodent and Human Stem Cell Derived Neurons. Nano Lett. 2017; 17(5):2757-2764. PMC: 6045931. DOI: 10.1021/acs.nanolett.6b04752. View

5.
Hovorka R, Allen J, Elleri D, Chassin L, Harris J, Xing D . Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet. 2010; 375(9716):743-51. DOI: 10.1016/S0140-6736(09)61998-X. View